新型二正丁基锡(Ⅳ)羧酸酯的合成、晶体结构及杀菌活性研究

在苯溶液中,将2-(2-甲酰基-6-甲氧基苯氧基)乙酸与二正丁基氧化锡进行脱水反应,获得新型二正丁基锡(Ⅳ)羧酸酯(1),经过元素分析、1HNMR和IR及晶体结构测定等手段对其进行了结构表征。锡原子为五配位,构成以锡为中心的扭曲三角双锥构型,三个双锡氧环构成具有对称结构的二聚体。中心环[Sn2O2]通过氧原子与两个环外锡原子相连,双齿配体羧基的两个氧原子分别与环内和环外锡原子配位,每个环外锡原子还与羧基形成单齿配位。此外还初步研究了其杀菌活性。     

N-1,3,4-(口恶)二唑基-N′-呋喃甲酰基硫脲的合成及杀菌活性研究

将呋喃环、1,3,4-(口恶)唑环2个杂环同时引入到酰基硫脲中,合成了10个未见报道的酰基硫脲类化合物. 所有化合物的结构均经元素分析、红外光谱、核磁共振氢谱和质谱确认. 抑菌法生物活性测试表明,各目标产物对黄瓜灰霉病菌的抑制效果较好,最高可达97%.     

4,4′-二（4-氯甲酰苯氧基）二苯砜的合成

以DMF作溶剂,在四丁基氟化铵 （TBAF）存在下,对甲基苯基三甲硅基醚（1）和4,4＇-二氯二苯砜（2）于100 ℃反应1 h,合成了4,4＇-二（4-甲基苯氧基）二苯砜（3）,产率为92%;加入催化量的N-溴代丁二酰亚胺（NBS）并在光照条件下,与氧气反应得到中间体-4,4＇-二（4-羧基苯氧基）二苯砜（4）,其产率达90%;将化合物4与二氯亚砜反应合成目标产物4,4＇-二（4-氯甲酰基苯氧基）二苯砜（5）,总收率为74.5%（以对甲基苯基三甲硅基醚为基准计算）.     

新型双大环二正丁基锡羧酸酯的合成、晶体结构及生物活性

在乙醇钠催化下, 将3-(1,2亚丙二硫基)亚甲基-2,4-二羰基戊烷与2-羰基苯氧乙酸进行缩合反应, 获得了柔性二元酸配体1[4-(1,2-亚丙二硫基)亚甲基-3,5-二羰基-1,6-庚二烯-1,7-二(2-羰基苯)氧乙酸(LH2)]. 再将配体1与二正丁基氧化锡进行脱水反应, 获得新型二正丁基锡羧酸酯配合物2. 采用元素分析、1H NMR、 IR及晶体结构测定等手段对配体1和配合物2进行了结构表征, 配合物2是以菱形环Sn2O2为中心对称的二聚体结构, 中心菱形环通过氧原子与2个环外锡原子相连. 每个羧基分别与环内锡和环外锡原子配位, 形成2个对称的六元环, 3个环呈梯形排列, 将整个分子分割成2个对称的二十二元大环. 初步研究了其杀菌活性和抗癌活性.     

N-1，3，4-噁二唑基-N′-呋喃甲酰基硫脲的合成及杀菌活性研究

N-1;3;4-噁二唑基-N′-呋喃甲酰基硫脲的合成及杀菌活性研究;呋喃;噁二唑;酰基硫脲;合成;杀菌活性     

N-(4,6-二取代嘧啶-2-基)-N'-(1-甲基-3-乙基-4-氯吡唑-5-基)甲酰基(硫)脲的合成及生物活性

利用活性结构拼接原理,将高效杀螨剂吡螨胺分子的吡唑环部分引入酰基（硫）脲化合物中,以1-甲基-3-乙基-4-氯-5-甲酸基吡唑和2-氨基-4,6-二取代嘧啶为起始原料,通过多步反应合成了5种N-（4,6-二取代嘧啶-2-基）-N’-（1-甲基-3-乙基-4-氯吡唑-5-基）甲酰基脲和5个N-（4,6-二取代嘧啶-2．基）-N’-（1．甲基-3-乙基-4-氯吡唑-5-基）甲酰基硫脲化合物,其化合物结构经IR、^1HNMR及元素分析测试技术确证。初步生物活性试验表明,在50mg／L质量浓度下目标化合物的杀螨活性不太理想,但有些化合物具有较好的除草活性,其中化合物Ib、Ic和Ie对稗草主根的生长抑制率大于60％。     

N-1，3，4-噁二唑基-N′-呋喃甲酰基硫脲的合成及杀菌活性研究

N-1;3;4-噁二唑基-N′-呋喃甲酰基硫脲的合成及杀菌活性研究;呋喃;噁二唑;酰基硫脲;合成;杀菌活性     

2-苯氧基乙酸苯胺超分子化合物的合成及其晶体结构

合成了2-苯氧基乙酸苯胺(1),其结构经X-射线单晶衍射表征.结果表明,1属于单斜晶系,P2(1)空间群,晶胞叁数为:a=13.422(3)A,b=6.740(17)A,c=15.645(4)A,α=90.000°,β=110.047(5)°,γ=90.000°,V=1 329.6(6)nm3Z=4,Dr=1.225 mg·cm-3,F(000)=520,μ=0.086 mm-1,R1=0.104 7,R2=0.059 1,ωR1=0.123 7,ωR2=0.107 9.1通过分子间氢键形成层状结构.     

N-(4,6-二取代嘧啶-2-基)-N′-(1-甲基-3-乙基-4-氯吡唑-5-基)甲酰基(硫)脲的合成及生物活性

利用活性结构拼接原理,将高效杀螨剂吡螨胺分子的吡唑环部分引入酰基(硫)脲化合物中,以1-甲基-3-乙基-4-氯-5-甲酸基吡唑和2-氨基-4,6-二取代嘧啶为起始原料,通过多步反应合成了5种N-(4,6-二取代嘧啶-2-基)-N′-(1-甲基-3-乙基-4-氯吡唑-5-基)甲酰基脲和5个N-(4,6-二取代嘧啶-2-基)-N′-(1-甲基-3-乙基-4-氯吡唑-5-基)甲酰基硫脲化合物,其化合物结构经IR、1HNMR及元素分析测试技术确证。初步生物活性试验表明,在50mg/L质量浓度下目标化合物的杀螨活性不太理想,但有些化合物具有较好的除草活性,其中化合物Ⅰb、Ⅰc和Ⅰe对稗草主根的生长抑制率大于60%。     

二{氧桥-二[N,N-二甲基(或乙基)氨荒酸基乙酸二丁基锡(Ⅳ)]}的合成及结构

利用二丁基氧化锡与N,N-二甲基氨荒酸基乙酸以及N,N-二乙基氨荒酸基乙酸反应,合成了二聚体有机锡化合物{[n-Bu2Sn(O2CCH2CS2NMe2)]2O}2 (1)和{[n-Bu2Sn(O2CCH2CS2NEt2)]2O}2 (2).通过元素分析,红外光谱及核磁共振谱对它们进行了表征.并用X射线单晶衍射法测定了这两个化合物的晶体结构,结果表明1为单斜晶系,C2/m空间群,晶胞参数为a=1.3584(5) nm, b=1.9242(7) nm, c=1.4640(5) nm, β=102.505(5)°, Z=2, V=3.736(2) nm3, μ=1.490 g/cm3, F(000)=1704, R1=0.0492, wR2=0.1159. 2为三斜晶系,P1-空间群,晶胞参数为a=1.1960(14) nm, b=1.3612(16) nm, c=1.3684(16) nm, α=90.969(18)°, β=105.241(17)°, γ=103.954(16)°, Z=1, V=2.078(4) nm3, μ=1.429 g/cm3, F(000)=916, R1=0.0459, wR2=0.0957.它们都是以Sn2O2四元环为中心对称的二聚体结构.但锡原子的配位方式不同,在1中,内外环锡原子均为五配位的畸变三角双锥构型;而在2中,内环锡原子为五配位的畸变三角双锥构型,而外环锡原子为六配位的加帽三角双锥构型.     

三(2-甲基-2-苯基丙基)锡(Ⅳ)三氯乙酸酯的合成、结构和生物活性

三氯乙酸与氧化双[三(2-甲基-2-苯基)丙基锡]反应,合成了新配合物三(2-甲基-2-苯基)丙基锡三氯乙酸酯（CCDC:932139）,经元素分析、1H NMR和IR等技术手段表征其组成和结构,通过X射线衍射方法测定了化合物的晶体结构。 该化合物晶体学参数：单斜晶系,空间群为P21/n,晶胞参数：a=1.1186(4) nm,b=1.8366(7) nm,c=1.6020(6) nm,α=90°,β=91.316(7)°,γ=90°,V=3.2902(19) nm3,Z=4,Dc=1.374 g/cm3,μ(MoKα)=1.046 mm-1,F(000)=1392,R1=0.0589,wR2=0.1619;中心锡原子呈四配位畸变四面体构型。 生物活性测试结果表明,标题配合物对5种肿瘤细胞株系HT-29、HepG-2、MCF-7、KB和A549均具有较好的体外抑制活性,并且具有选择性的抑菌活性。     

Synthesis,Crystal Structure and Antibacterial Activity of （2E,3E）-N1,N2-Bis（2,3,4-trimethoxy-6-methylbenzylidene）ethane-1,2-diamine

The title compound （2E,3E）-N1,N2-bis（2,3,4-trimethoxy-6-methylbenzylidene）- ethane-l,2-diamine （C24H32N2O6, Mr = 444.52） was synthesized and characterized by elemental analysis, IR spectra and single-crystal X-ray diffraction. The crystal belongs to triclinic, space group P2/c, with a = 8.5480（10）, b = 9.3710（12）, c = 15.280（2）A, β = 90.780（2）°, V= 1223.9（3）A3, Z = 2, Dc= 1.206 g/cm3, 2 = 0.71073A,μ（MoKa） = 0.087 mm^-1, F（000） = 476, the final R = 0.0680 and wR = 0.1450 for 2144 observed reflections with I 〉 2σ（I）. X-ray diffraction analysis reveals that the molecule adopts an E configuration about the central C=N functional bond. The phenyl rings of two 2,3,4-trimethoxy-6-methylbenzaldehyde groups are symmetrically parallel. The molecules are linked through C-H…O hydrogen bonding interactions. The title compound possesses moderate antibacterial activity.     

Synthesis,Crystal Structure and Antibacterial Activity of （E）-N1,N4-Bis（2,3,4-trimethoxy-6- methylbenzylidene）butane- 1,4-diamine

The title compound （E）-N1,N4-bis（2,3,4-trimethoxy-6-methylbenzylidene） butane- 1,4- diamine （C26H36N2O6, Mr = 472.57） was synthesized and characterized by elemental analysis, IR spectra and single-crystal X-ray diffraction. The crystal belongs to triclinic, space group C2/c with a = 36.102（4）, b = 5.6620（11）, c = 13.015（2）A,β = 105.491 （2）°, V = 2563.7（7）A3, Z = 4, Dc = 1.224 g/cm3, 2 = 0.71073 A,μ（MoKα） = 0.087 mm^-1, F（000） = 1016, the final R = 0.0456 and wR = 0.1257 for 2255 observed reflections with I 〉 2σ（I）. X-ray diffraction analysis reveals that the molecule adopts an E configuration about the central C=N functional bond. The phenyl rings of two 2,3,4-trimethoxy-6-methylbenzaldehyde groups are parallel by symmetry. The molecules are linked through π-π and C-H…π stacking interactions and C-H…O hydrogen bonding interactions. The title compound possesses moderate antibacterial activity.     

二(2-吡啶甲酸)二苯基锡(Ⅳ)配合物的合成及晶体结构

The complex (2-pyridinecarboxylato)₂diphenyltin(Ⅳ) was synthesized by the reaction of 2-pyridinecarboxylic acids with the diphenyltin(Ⅳ) oxide. The crystal structure was determined by X-ray diffraction. The crystal belongs to monoclinic with space group P2₁/n， a=1.46504(19)nm， b=1.01225(13)nm， c=1.45406(19)nm， β=94.849(2)°， Z=4， R₁=0.0285， wR₂=0.0672. In this complex， the tin atom rendered six-coordinate in a distorted octahedron geometry. Each central tin atom is surrounded equatorial by two oxygen atoms coming from two carboxyl groups， one nitrogen atom coming from pyridinyl group and one carbon atom of the penyl group and axially by one carbon atom of the phenyl group and one nitrogen atom coming from pyridinyl group. CCDC： 180021.     

Synthesis,Crystal Structure and Antibacterial Activity of Dibenzyl Dithiocarbamate Bismuth Complex

A new complex, {Bi(Ⅲ)[S2CN(CH2C6H5)2]3}2·2CH3CN, was synthesized and characterized by elemental analysis, IR, TG, 1H NMR and X-ray single-crystal diffraction. The complex crystallizes in the triclinic system, space group P1, with a = 12.705(6), b = 13.430(6), c = 15.489(12) , α = 102.135(12), β = 99.649(12), γ = 111.521(9)°, Z = 1, V = 2315(2) A3, Dc = 1.531 g·cm-3, F(000) = 1068, μ = 4.116 mm-1, the final R = 0.0559, w R = 0.1069 and S =1.056. The coordinated geometry of Bi(Ⅲ) with six sulfur atoms from three ligands is a distorted pentagonal pyramidal configuration, and the structural system is formed by weak interactions of Bi···S between two molecules. The complex was valued for its antibacterial activity by agar-streak method. It was found that the complex is weakly active against three of the five tested bacterial organisms.     

(Z)-1[2-(苯基二溴化锡基)乙烯基]-1-环己醇的合成及晶体结构

报道了标题化合物〔C14H18Br2OSn〕的合成及晶体结构。该晶体属于单斜晶系，空间点群为P21/c，晶胞参数a=11.711(2)，b=9．114（2），c=16．864（3）A，β=102.94（1）°，V=1604.55（0）A3，Mr=480．78，Z=4，Dc=1．99g／cm3，u=65．20cm－1，F（000）=919，R=0．050，Rw=0．050．晶体结构由直接法解出。标题化合物分子中的锡原子被配体的2个碳、2个溴和1个氧原子配位，配位原子呈畸变的三角双锥构型，环已基为椅式构象，五员杂环为信封构象。     

三正丁基锡3-氨基-2-吡嗪甲酸酯聚合物的合成、结构和电化学性质研究

The tri(n-butyl)tin 3-amino-2-pyrazine formic ester polymer [n-Bu₃Sn(O₂CC₄H₂N₂NH₂-o)]_n has been synthesized and characterized by IR, ¹H NMR spectra and elemental analysis. Its crystal structure has been determined by X-ray diffraction. The crystal belongs to monoclinic space group P2₁/c with a=1.057 7(2) nm, b=1.083 6(2) nm, c=1.905 2(4) nm, β=100.604(3)°, Z=4, V=2.146 3(8) nm³, D_c=1.325 Mg·m^-3, μ(Mo Kα)=1.202 mm^-1, F(000)=880, R₁=0.039 3, wR₂=0.113 3. In the complex, tin atoms are five-coordinated distorted trigonal bipyramid configuration. Through the intermolecular N-H…N hydrogen bonds to form network structure with a “double bridge”. The result of analysis shows that the Sn(Ⅳ)/Sn(Ⅱ) electron transfer in electrode reaction is irreversible. CCDC: 779860.     

Synthesis, Crystal Structure and Antibacterial Activity of Two Hydrazones Derived from 2-Fluorobenzhydrazide

Two new Schiff base benzoyl hydrazone compounds, C14H10FN3O3 (Ⅰ) and C14H10F2N2O (Ⅱ), have been synthesized and characterized by elemental analysis, IR, UV and X-ray single-crystal diffraction. Both compounds crystallize in monoclinic, space group P21/c with a = 7.0514(14), b = 25.928(5), c = 7.7099(15), β = 111.823(2)°, V = 1308.6(4)3, Z = 4, C14H10FN3O3, Mr = 287.25, Dc = 1.458 g/cm3, μ(MoKα) = 0.115 mm-1, F(000) = 592, the final R = 0.0841 and wR = 0.2489 for 1901 observed reflections (I > 2σ(I)) for I; a = 11.232(3), b =12.735(4), c = 8.612(2) , β = 90.869(3)°, V = 1231.7(6)3, Z = 4, C14H10F2N2O, Mr = 260.24, Dc = 1.403 g/cm3, μ(MoKα) = 0.111 mm-1, F(000) = 536, the final R = 0.0453 and wR = 0.1085 for 1317 observed reflections (I > 2σ(I)) for Ⅱ. The antibacterial activities of both compounds against two bacteria were first studied and one compound showed considerable antibacterial activity against K. Pneumonia and S. aureus.     

Synthesis,Crystal Structure and Antifungal Activity of N-（Pyridine-2-methyl）-2-（4- chlorophenyl）-3-methylbutanamide

A novel compound N-（pyridine-2-methyl）-2-（4-chlorophenyl）-3-methylbutanamide, a racemic compound, has been synthesized with 2-（4-chlorophenyl）-3-methylbutyric acid and pyridin- 2-methylanamine as the raw materials, and its crystal structure （C17H19C1N2O, Mr = 302.79） was determined by single-crystal X-ray diffraction analysis. The crystal belongs to monoclinic, space group P21/n with a = 9.624（9）, b = 23.14（2）, c = 15.626（15）A, β = 106.199（14）°, V = 3342（5） A^3, Z = 8, Dc = 1.204 g/cm^3,μ = 0.23 mm^-1, F（000） = 1280, S = 1.032, R = 0.0681 and wR = 0.1508 for 6513 unique reflections （Rint = 0.0421） with 3375 observed ones. In the crystal structure, there are some intermolecular hydrogen bonds which stabilize the crystal structure. The preliminary bioassay shows that the title compound exhibits good antifungal activity against Botrytis cinerea, Gibberella zeae, Dothiorella gregaria and Colletotrichum gossypii.